Trust Point Inc’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-818
Closed -$239K 521
2026
Q1
$239K Sell
818
-41
-5% -$13.5K 0.02% 456
2025
Q4
$301K Sell
859
-119
-12% -$40.2K 0.02% 372
2025
Q3
$316K Buy
+978
New +$304K 0.03% 353
2025
Q2
Sell
-622
Closed -$271K 434
2025
Q1
$271K Sell
622
-197
-24% -$79.1K 0.02% 367
2024
Q4
$302K Sell
819
-38
-4% -$15.9K 0.02% 420
2024
Q3
$446K Buy
857
+9
+1% +$4.81K 0.03% 304
2024
Q2
$459K Sell
848
-246
-22% -$130K 0.04% 277
2024
Q1
$567K Buy
1,094
+14
+1% +$6.96K 0.04% 262
2023
Q4
$509K Buy
+1,080
New +$499K 0.04% 269

Other funds holding ELV

Trust Point Inc's ELV Position: Q2 2026 in Review

Trust Point Inc sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 818 shares — an estimated $239K sold.

Trust Point Inc first reported a position in ELV in Q4 2023 and held it in 9 quarters. The position peaked at $567K in Q1 2024. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Trust Point Inc reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Trust Point Inc sold 818 Elevance Health shares in Q2 2026, an estimated $239K.
  • Trust Point Inc first reported a position in Elevance Health in Q4 2023 and held it in 9 quarters.
  • Trust Point Inc's Elevance Health position peaked at $567K in Q1 2024.
  • 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Trust Point Inc's 13F filing for Q2 2026, filed 8 Jul 2026.